GL
Globe Life Inc.140.74
+0.09+0.06%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
11.40BP/E (TTM)
10.21Basic EPS (TTM)
13.78Dividend Yield
0.01%Recent Filings
8-K
SERP early retirement eased
Globe Life amended its Supplemental Executive Retirement Plan effective November 5, 2025, easing early retirement reductions to as low as 50% at age 55 while boosting change-of-control protections. Executives in the Severance Plan facing qualifying terminations during protection periods gain deemed vesting at age 55 minimums, no extra credited service. Ties exec pay tighter to retention amid M&A risks.
10-Q
Q3 FY2025 results
Globe Life posted Q3 net income of $388M, up 28% y/y, with diluted EPS $4.73 (up 38%) on total premium of $1.23B (+5% y/y). Life premium rose 3% y/y to $844M while health jumped 9% y/y to $387M, fueled by 5% higher agent counts across exclusives; underwriting margins expanded on $150M pre-tax remeasurement gains from favorable mortality/lapse assumptions (vs $71M y/y). Operating cash flow hit $1.05B YTD; cash $303M with $554M revolver availability backs $2.7B debt. Building buy closed July 2025 for $80M to boost ops. Ongoing securities litigation poses resolution risk.
8-K
Q3 earnings beat expectations
Globe Life Inc. reported Q3 2025 net operating income of $4.81 per diluted share, up 38% from $3.49 a year ago, fueled by a $134.3 million remeasurement gain from updated assumptions. Life premiums rose 3% to $844.5 million, health premiums climbed 9% to $386.5 million, while underwriting margins surged 24% for life and 25% for health. The company repurchased $113 million in shares. Guidance holds net operating income at $14.40–$14.60 per share for 2025.
10-Q
Q2 FY2025 results
Globe Life's Q2 FY2025 results showed steady topline momentum, with total premium up 4% y/y to $1.22B (derived) and life premium rising 3% y/y to $840M, while health premium grew 8% y/y to $378M; underwriting margins held firm at 41% for life (up from 39% y/y) but dipped to 24% for health from 28% y/y amid higher claims utilization. Diluted EPS of $3.05 aligned with net income of $253M on 83M shares, down 2% y/y yet supported by $71M excess investment income (down 18% y/y, derived). Cash swelled to $239M with $740M operating inflows (up 2% y/y, derived), funding $514M share repurchases; debt stood at $2.8B with $488M revolver availability. A $14M reinsurance recapture gain aided life margins. Ongoing securities litigation poses a balanced risk to operations.
8-K
SEC and DOJ probes closed
Globe Life Inc. wrapped up its SEC investigation on July 24, 2025, with regulators opting against any enforcement action. The Department of Justice followed suit on July 28, closing its probe into the company and subsidiary American Income Life Insurance Company. No penalties emerged. This clears a major overhang, letting Globe Life refocus on its core insurance operations without regulatory drag.
IPO
Employees
Sector
Industry
AFL
AFLAC Incorporated
109.49-2.01
BHF
Brighthouse Financial, Inc.
65.28-0.07
CIA
Citizens, Inc.
5.70+0.35
CILJF
China Life Insurance Company Li
3.52-0.16
CNO
CNO Financial Group, Inc.
42.88+0.01
GNW
Genworth Financial Inc
8.97-0.02
LNC
Lincoln National Corporation
45.30+0.10
MET
MetLife, Inc.
82.28-0.33
PRI
Primerica, Inc.
258.02-0.56
SLF
Sun Life Financial Inc.
61.27+0.43